Neuberger Berman Group »

Atrium Therapeutics shares owned by Neuberger Berman Group

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Neuberger Berman Group from 13F filings

Historical chart of Neuberger Berman Group investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by Neuberger Berman Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $927k 69k 13.37

More positions owned by Neuberger Berman Group

Nvidia Corp Common (NVDA)
Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Amazon Common (AMZN)
Alphabet Inc Class A A Common (GOOGL)
Alphabet Inc-cl C Common (GOOG)
Jpmorgan Chase & Co Common (JPM)
Eli Lilly & Co Common (LLY)
Ishares Core S&p 500 Etf Etf (IVV)
Meta Platforms Inc Class A A Common (META)
Broadcom Common (AVGO)
Nextera Energy Common (NEE)
Home Depot Common (HD)
Exxon Mobil Corp Common (XOM)
Asml Holding Adr Representing Nv Common (ASML)

View all positions for Neuberger Berman Group

Top funds holding Atrium Therapeutics

BlackRock
Susquehanna International
RA Capital Management
Vanguard Capital Management
TIG Advisors
Pentwater Capital Management
Sessa Capital IM
Goldman Sachs Group
Farallon Capital Management
Vanguard Portfolio Management
Geode Capital Management
683 Capital Management
Bellevue Group
State Street Corporation
Weiss Asset Management LP[1

View all funds holding Atrium Therapeutics